EMULCO LABORATORIES
ActiveSummary
EMULCO LABORATORIES has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-119k) and a net result of €-320k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 8001 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Credit check for your own amount and term
Signals
Checked, nothing found (2)
Financials · fiscal year 2025, abbreviated schema
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Directors · office · real estate
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Henri Farmanstraat 259000 Gent1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44812P0639/00G020 | Flanders | 4.6 ha | 1 · 286 m² | 4.7 m · 1 fl. |
Linked by address, not proof of ownership
Public money · subsidies and aid
Flemish government
2022 to 2024 · 4 entries · 3,966 EUR awarded · 3,966 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 36 EUR | 0 EUR |
| 2023 | 2 | 3,898 EUR | 3,934 EUR |
| 2022 | 1 | 32 EUR | 32 EUR |
Similar companies · same sector, comparable size
Company data · Crossroads Bank
Scores and ratios are computed by Checked and are not a credit decision.